Frequency of health-care utilization by adults who use illicit drugs: a systematic review and meta-analysis
- PMID: 31705770
- PMCID: PMC7210080
- DOI: 10.1111/add.14892
Frequency of health-care utilization by adults who use illicit drugs: a systematic review and meta-analysis
Abstract
Aims: To summarize evidence on the frequency and predictors of health-care utilization among people who use illicit drugs.
Design: Systematic search of MEDLINE, EMBASE and PsychINFO for observational studies reporting health-care utilization published between 1 January 2000 and 3 December 2018. We conducted narrative synthesis and meta-analysis following a registered protocol (identifier: CRD42017076525).
Setting and participants: People who use heroin, powder cocaine, crack cocaine, methamphetamine, amphetamine, ecstasy/3,4-methylenedioxymethamphetamine (MDMA), cannabis, hallucinogens or novel psychoactive substances; have a diagnosis of 'substance use disorder'; or use drug treatment services.
Measurements: Primary outcomes were the cumulative incidence (risk) and rate of care episodes in three settings: primary care, hospital admissions (in-patient) and emergency department (ED).
Findings: Ninety-two studies were included, 84% from North America and Australia. Most studies focused on people using heroin, methamphetamine or crack cocaine, or who had a diagnosis of drug dependence. We were able to conduct a meta-analysis of rates across 25 studies reporting ED episodes and 25 reporting hospital admissions, finding pooled rates of 151 [95% confidence interval (CI) = 114-201] and 41 (95% CI = 30-57) per 100 person-years, respectively; on average 4.8 and 7.1 times more often than the general population. Heterogeneity was very high and was not explained by drugs used, country of study, recruitment setting or demographic characteristics. Predictors of health-care utilization were consistent across studies and included unstable housing, drug injection and mental health problems. Opioid substitution therapy was consistently associated with reduced ED presentation and hospital admission. There was minimal research on health-care utilization by people using ecstasy/MDMA, powder cocaine, hallucinogens or novel psychoactive substances.
Conclusions: People who use illicit drugs are admitted to emergency department or hospital several times more often than the general population.
Keywords: Health services; Hospitals; Opiates; Primary Health Care; Stimulants; Substance-Related Disorders.
© 2019 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.
Figures





Similar articles
-
Prevalence of psychotic symptoms in substance users: a comparison across substances.Compr Psychiatry. 2009 May-Jun;50(3):245-50. doi: 10.1016/j.comppsych.2008.07.009. Epub 2008 Sep 23. Compr Psychiatry. 2009. PMID: 19374969 Free PMC article.
-
A cohort study examining emergency department visits and hospital admissions among people who use drugs in Ottawa, Canada.Harm Reduct J. 2017 May 12;14(1):16. doi: 10.1186/s12954-017-0143-4. Harm Reduct J. 2017. PMID: 28494791 Free PMC article.
-
Disparities in Use/Misuse of Specific Illicit and Prescription Drugs among Sexual Minority Adults in a National Sample.Subst Use Misuse. 2022;57(3):461-471. doi: 10.1080/10826084.2021.2019776. Epub 2022 Jan 22. Subst Use Misuse. 2022. PMID: 35067155
-
Rates and Patterns of Australian Emergency Department Presentations of People Who Use Stimulants: A Systematic Literature Review.Cureus. 2022 Oct 18;14(10):e30429. doi: 10.7759/cureus.30429. eCollection 2022 Oct. Cureus. 2022. PMID: 36407224 Free PMC article. Review.
-
Illicit drug use and treatment in South Africa: a review.Subst Use Misuse. 2010 Nov;45(13):2221-43. doi: 10.3109/10826084.2010.481594. Subst Use Misuse. 2010. PMID: 21039113 Free PMC article. Review.
Cited by
-
Improving access to pulmonary rehabilitation for patients with COPD treated for substance misuse in the London Borough of Islington.BMJ Open Qual. 2025 Jan 22;14(1):e003002. doi: 10.1136/bmjoq-2024-003002. BMJ Open Qual. 2025. PMID: 39843359 Free PMC article.
-
The hospital admission profile of people presenting to specialist addiction services with problematic use of alcohol or opioids: A national retrospective cohort study in England.Lancet Reg Health Eur. 2021 Apr;3:100036. doi: 10.1016/j.lanepe.2021.100036. Lancet Reg Health Eur. 2021. PMID: 33969334 Free PMC article.
-
Multimorbidity, psychoactive substance use and psychological distress among acute medically ill patients: a cross-sectional study.BMJ Open. 2021 Nov 23;11(11):e052428. doi: 10.1136/bmjopen-2021-052428. BMJ Open. 2021. PMID: 34815283 Free PMC article.
-
Trends and correlates of abscess history among people who inject drugs in Massachusetts: A mixed methods exploration of experiences amidst a rapidly evolving drug supply.Drug Alcohol Depend Rep. 2023 Jun 16;8:100176. doi: 10.1016/j.dadr.2023.100176. eCollection 2023 Sep. Drug Alcohol Depend Rep. 2023. PMID: 37753348 Free PMC article.
-
Hospital admissions among patients with Comorbid Substance Use disorders: a secondary analysis of predictors from the NavSTAR Trial.Addict Sci Clin Pract. 2024 Apr 28;19(1):33. doi: 10.1186/s13722-024-00463-9. Addict Sci Clin Pract. 2024. PMID: 38678216 Free PMC article. Clinical Trial.
References
-
- Aldridge R. W., Story A., Hwang S. W., Nordentoft M., Luchenski S. A., Hartwell G., et al Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high‐income countries: a systematic review and meta‐analysis. Lancet 2018; 391: 241–250. - PMC - PubMed
-
- Degenhardt L., Larney S., Randall D., Burns L., Hall W. Causes of death in a cohort treated for opioid dependence between 1985 and 2005: mortality among opioid‐dependent people. Addiction 2014; 109: 90–99. - PubMed
-
- Degenhardt L., Bucello C., Mathers B., Briegleb C., Ali H., Hickman M., et al Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta‐analysis of cohort studies: mortality among opioid users. Addiction 2011; 106: 32–51. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- MC_UU_12017/13/MRC_/Medical Research Council/United Kingdom
- R01 DA037820/DA/NIDA NIH HHS/United States
- DRF-2018-11-ST2-016/DH_/Department of Health/United Kingdom
- SPHSU17/CSO_/Chief Scientist Office/United Kingdom
- SPHSU13/CSO_/Chief Scientist Office/United Kingdom
- CAF/17/11/CSO_/Chief Scientist Office/United Kingdom
- 109823/WT_/Wellcome Trust/United Kingdom
- SPHSU15/CSO_/Chief Scientist Office/United Kingdom
- R01 DA044170/DA/NIDA NIH HHS/United States
- CDF-2016-09-014/DH_/Department of Health/United Kingdom
- MC_UU_12017/15/MRC_/Medical Research Council/United Kingdom